Evidence map›Paper›PMID 22253604›Full record

ArticlePLoS genetics2012

An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production.

Gregory M Ku, Zachary Pappalardo, Chun Chieh Luo, Michael S German, Michael T McManus

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Which Hyperglycemic Model of Zebrafish (Frontiers in cell and developmental biology · 2021
    Review
  17. Article
  18. Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gregory M KuDiabetes Center, University of California San Francisco, CA, USA.
Zachary Pappalardo
Chun Chieh Luo
Michael S German
Michael T McManus
University of California, San Francisco · US

Funding

Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GERMAN, MICHAEL S · 2003 to 2019
$21.8M
DIABETES, ENDOCRINOLOGY &METABOLISM TRAINING PROGRAMT32DK007418 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARD C HSIAO · 1986 to 2026
$14.3M
"Expanding beta-cell mass"U01DK089541 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GERMAN, MICHAEL S, HEBROK, MATTHIAS · 2010 to 2014
$5.1M
DIFFERENTIATION IN THE ENDOCRINE AND EXOCRINE PANCREASR01DK021344 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GERMAN, MICHAEL S · 1986 to 2014
$3.4M
New Frontiers for Small RNA TherapiesR01GM080783 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCMANUS, MICHAEL T · 2007 to 2011
$1.5M
Whole genome RNA-interference screen for novel regulators of the insulin promoterRC1DK086290 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCMANUS, MICHAEL T · 2009 to 2010
$995k
Discovering and dissecting new regulators of insulin production in beta cellsK08DK087945 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KU, GREGORY MICHAEL · 2011 to 2015
$747k
NIDDK NIH HHS DK063720NIDDK NIH HHS DK07418NIDDK NIH HHS DK086290NIDDK NIH HHS DK087945NIDDK NIH HHS K08 DK087945NIDDK NIH HHS P30 DK063720NIDDK NIH HHS R01 DK021344NIDDK NIH HHS RC1 DK086290NIDDK NIH HHS T32 DK007418NIDDK NIH HHS U01 DK089541NIGMS NIH HHS GM080783NIGMS NIH HHS R01 GM080783
6 · The paper itself

Abstract

The prevalence of type 2 diabetes in the United States is projected to double or triple by 2050. We reasoned that the genes that modulate insulin production might be new targets for diabetes therapeutics. Therefore, we developed an siRNA screening system to identify genes important for the activity of the insulin promoter in beta cells. We created a subclone of the MIN6 mouse pancreatic beta cell line that expresses destabilized GFP under the control of a 362 base pair fragment of the human insulin promoter and the mCherry red fluorescent protein under the control of the constitutively active rous sarcoma virus promoter. The ratio of the GFP to mCherry fluorescence of a cell indicates its insulin promoter activity. As G protein coupled receptors (GPCRs) have emerged as novel targets for diabetes therapies, we used this cell line to screen an siRNA library targeting all known mouse GPCRs. We identified several known GPCR regulators of insulin secretion as regulators of the insulin promoter. One of the top positive regulators was Gpr27, an orphan GPCR with no known role in beta cell function. We show that knockdown of Gpr27 reduces endogenous mouse insulin promoter activity and glucose stimulated insulin secretion. Furthermore, we show that Pdx1 is important for Gpr27's effect on the insulin promoter and insulin secretion. Finally, the over-expression of Gpr27 in 293T cells increases inositol phosphate levels, while knockdown of Gpr27 in MIN6 cells reduces inositol phosphate levels, suggesting this orphan GPCR might couple to Gq/11. In summary, we demonstrate a MIN6-based siRNA screening system that allows rapid identification of novel positive and negative regulators of the insulin promoter. Using this system, we identify Gpr27 as a positive regulator of insulin production.

Indexed as

Promoter Regions, GeneticAnimalsCell LineDiabetes Mellitus, Type 2Gene Expression RegulationGene Knockdown TechniquesGlucoseHEK293 CellsHomeodomain ProteinsHumansInositol PhosphatesInsulinInsulin-Secreting CellsInsulin SecretionMiceReceptors, G-Protein-CoupledGlucoseGpr27 protein, mouseHomeodomain ProteinsInositol PhosphatesInsulinpancreatic and duodenal homeobox 1 proteinReceptors, G-Protein-CoupledRNA, Small InterferingTrans-Activators

Identifiers

PMID22253604
PMCPMC3257298
OpenAlexW2149537558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.